Nature Reviews Gastroenterology & Hepatology is a peer-reviewed medical journal published by Nature Portfolio. It was established in 2004 as Nature Clinical Practice Gastroenterology & Hepatology and obtained its current title in April 2009. The editor-in-chief is Katrina Ray.
Natural Product Reports is a monthly peer-reviewed scientific journal published by the Royal Society of Chemistry. It publishes reviews commissioned by the editorial board on all areas of natural products research. The editors-in-chief is Tobias Gulder.
Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field.
Energy & Environmental Science is a monthly peer-reviewed scientific journal publishing original (primary) research and review articles. The journal covers work of an interdisciplinary nature in the biochemical and biophysical sciences and chemical and mechanical engineering disciplines. It covers energy area. Energy & Environmental Science is published by the Royal Society of Chemistry.
The Journal of Enzyme Inhibition and Medicinal Chemistry is a peer-reviewed open access medical journal published by Taylor & Francis that covers research on enzyme inhibitors and inhibitory processes as well as agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents. The editor-in-chief is Claudiu T. Supuran.
Nature Chemistry is a monthly peer-reviewed scientific journal published by Nature Portfolio. It was established in April 2009. The editor-in-chief is Stuart Cantrill. The journal covers all aspects of chemistry. Publishing formats include primary research articles, reviews, news, views, highlights of notable research from other journals, commentaries, book reviews, correspondence. Other formats are analysis of issues such as education, funding, policy, intellectual property, and the impact chemistry has on society.
Metallomics is a monthly peer-reviewed scientific journal covering the growing research field of metallomics. The journal's scope is aimed at "elucidating the identification, distribution, dynamics, role and impact of metals and metalloids in biological systems". It is published by the Royal Society of Chemistry. The executive editor is Jeanne Andres, while the current chair of the editorial board is David Giedroc at Indiana University Bloomington.
Current Alzheimer Research is a peer-reviewed medical journal covering the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer's disease.
Current Molecular Medicine is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Andras Guttman. The journal covers research on molecular mechanisms of disease pathogenesis, the development of molecular diagnosis, and/or novel approaches to rational treatment. Formats of publication include original research reports, review papers, and rapid communications ("letters").
Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Liang Cheng. The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters").
Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang. The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters").
Current Topics in Medicinal Chemistry is a biweekly peer-reviewed medical journal published by Bentham Science Publishers. It includes review articles on all aspects of medicinal chemistry, including drug design. The current editor-in-chief is Jia Zhou.
The Open Clinical Biochemistry Journal is a peer-reviewed open-access medical journal, which publishes research articles, reviews, and letters in all areas of clinical chemistry and laboratory medicine.
The Open Ecology Journal is an open-access peer-reviewed scientific journal covering ecology. It publishes original research articles and reviews.
Combinatorial Chemistry & High Throughput Screening is a peer-reviewed scientific journal that covers combinatorial chemistry. It was established in 1998 and is published by Bentham Science Publishers. The editor-in-chief is Gerald H. Lushington. The journal has 5 sections: Combinatorial/ Medicinal Chemistry, Chemo/Bio Informatics, High Throughput Screening, Pharmacognosy, and Laboratory Automation.
ACS Photonics is a monthly, peer-reviewed, scientific journal, first published in January 2014 by the American Chemical Society. The current editor in chief is Romain Quidant. The interdisciplinary journal publishes original research articles, letters, comments, reviews and perspectives.
Mini-Reviews in Medicinal Chemistry is a monthly peer-reviewed medical journal covering all aspects of medicinal chemistry. It is published by Bentham Science Publishers and the editors-in-chief are Atta-ur-Rahman, M. Iqbal Choudhary, and George Perry.
Mark S. Cushman is an American chemist, whose primary research is in the area of medicinal chemistry. He completed his pre-pharmacy studies at Fresno State College (now California State University, Fresno) in 1965. He then attended the University of California San Francisco (as a University of California Regents Scholar), earning a Pharm.D. in 1969 and a Ph.D. in Medicinal Chemistry in 1973. Thereafter, he performed postdoctoral training in the laboratory of George Büchi, Ph.D., at the Massachusetts Institute of Technology (MIT). There, his research focused on the discovery and development of new synthetic methodologies, and the isolation and structural characterization of mycotoxins from Aspergillus niger. In 1975, he joined the Department of Medicinal Chemistry and Molecular Pharmacology (at the time, Department of Medicinal Chemistry and Pharmacognosy) at Purdue University. From 1983 to 1984, Prof. Cushman was a Senior Fulbright Scholar at Munich Technical University working in the laboratory of Professor Adelbert Bacher. His sabbatical work dealt with the design and synthesis of probes to elucidate key aspects of the biosynthesis of riboflavin (vitamin B2). Currently he holds the rank of Distinguished Professor Emeritus of Medicinal Chemistry at Purdue University. He has mentored 40 graduate students, 59 postdoctoral researchers, and 5 visiting scholars. He has published 348 papers and holds 41 patents. His work has ~17,000 citations with an h-index of 69. His most cited papers had 471, 403, and 299 citations as of August 2021. He has made seminal contributions to the fields of synthetic and medicinal chemistry including the development of new synthetic methodologies, the synthesis of natural products, and the preparation of antivirals, antibacterials, and anticancer agents, and mechanism probes to understand the function of over thirty macromolecular targets. One of his main scientific contributions is the development of the indenoisoquinolines, molecules that inhibit the action of toposiomerase I (Top1) and stabilize the G-quadruplex in the Myc promoter. Three indenoisoquinolines designed and synthesized by his research group at Purdue University [indotecan (LMP 400), indimitecan (LMP 776), and LMP 744] demonstrated potent anticancer activity in vivo and have completed phase I clinical trials at the National Institutes of Health.
Anti-Cancer Agents in Medicinal Chemistry is a peer-reviewed academic journal covering the disciplines of medicinal chemistry and drug design relating to chemotherapeutic agents in cancer. It is published by Bentham Science Publishers and the editor-in-chief is Simone Carradori. The journal covers developments in "medicinal chemistry and rational drug design for the discovery of anti-cancer agents" and publishes original research reports and review papers.
Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business / market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. In the academy and the scientific community, Clarivate is known for being the company which calculates the impact factor, using data from its Web of Science product family, that also includes services/applications such as Publons, EndNote, EndNote Click, and ScholarOne. Its other product families are Cortellis, DRG, CPA Global, Derwent, MarkMonitor, CompuMark, and Darts-ip, and also the various ProQuest products and services.
